Literature DB >> 25227604

Molecular regulation of cell fate in cerebral ischemia: role of the inflammasome and connected pathways.

George Trendelenburg1.   

Abstract

Analogous to Toll-like receptors, NOD-like receptors represent a class of pattern recognition receptors, which are cytosolic and constitute part of different inflammasomes. These large protein complexes are activated not only by different pathogens, but also by sterile inflammation or by specific metabolic conditions. Mutations can cause hereditary autoinflammatory systemic diseases, and inflammasome activation has been linked to many multifactorial diseases, such as diabetes or cardiovascular diseases. Increasing data also support an important role in different central nervous diseases such as stroke. Thus, the current knowledge of the functional role of this intracellular 'master switch' of inflammation is discussed with a focus on its role in ischemic stroke, neurodegeneration, and also with regard to the recent data which argues for a relevant role in other organs or biologic systems which influence stroke incidence or prognosis.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25227604      PMCID: PMC4269743          DOI: 10.1038/jcbfm.2014.159

Source DB:  PubMed          Journal:  J Cereb Blood Flow Metab        ISSN: 0271-678X            Impact factor:   6.200


  147 in total

1.  Prion-like polymerization underlies signal transduction in antiviral immune defense and inflammasome activation.

Authors:  Xin Cai; Jueqi Chen; Hui Xu; Siqi Liu; Qiu-Xing Jiang; Randal Halfmann; Zhijian J Chen
Journal:  Cell       Date:  2014-03-13       Impact factor: 41.582

2.  The NAD-dependent deacetylase sirtuin 2 is a suppressor of microglial activation and brain inflammation.

Authors:  Teresa Faria Pais; Éva M Szegő; Oldriska Marques; Leonor Miller-Fleming; Pedro Antas; Patrícia Guerreiro; Rita Machado de Oliveira; Burcu Kasapoglu; Tiago Fleming Outeiro
Journal:  EMBO J       Date:  2013-09-06       Impact factor: 11.598

3.  A role for mitochondria in NLRP3 inflammasome activation.

Authors:  Rongbin Zhou; Amir S Yazdi; Philippe Menu; Jürg Tschopp
Journal:  Nature       Date:  2010-12-01       Impact factor: 49.962

4.  Increased interleukin-10 production by ASC-deficient CD4+ T cells impairs bystander T-cell proliferation.

Authors:  Sharmal Narayan; Laeticia Kolly; Alexander So; Nathalie Busso
Journal:  Immunology       Date:  2011-06-30       Impact factor: 7.397

5.  Inflammasome-mediated secretion of IL-1β in human monocytes through TLR2 activation; modulation by dietary fatty acids.

Authors:  Ryan G Snodgrass; Shurong Huang; Il-Whan Choi; John C Rutledge; Daniel H Hwang
Journal:  J Immunol       Date:  2013-09-16       Impact factor: 5.422

6.  Intermittent fasting attenuates increases in neurogenesis after ischemia and reperfusion and improves recovery.

Authors:  Silvia Manzanero; Joanna R Erion; Tomislav Santro; Frederik J Steyn; Chen Chen; Thiruma V Arumugam; Alexis M Stranahan
Journal:  J Cereb Blood Flow Metab       Date:  2014-02-19       Impact factor: 6.200

7.  The Nlrp3 inflammasome promotes age-related thymic demise and immunosenescence.

Authors:  Yun-Hee Youm; Thirumala-Devi Kanneganti; Bolormaa Vandanmagsar; Xuewei Zhu; Anthony Ravussin; Ayinuer Adijiang; John S Owen; Michael J Thomas; Joseph Francis; John S Parks; Vishwa Deep Dixit
Journal:  Cell Rep       Date:  2012-01-26       Impact factor: 9.423

8.  Silent information regulator 1 protects the brain against cerebral ischemic damage.

Authors:  Macarena Hernández-Jiménez; Olivia Hurtado; María I Cuartero; Iván Ballesteros; Ana Moraga; Jesús M Pradillo; Michael W McBurney; Ignacio Lizasoain; María A Moro
Journal:  Stroke       Date:  2013-05-30       Impact factor: 7.914

9.  TLR2 has a detrimental role in mouse transient focal cerebral ischemia.

Authors:  Gina Ziegler; Denise Harhausen; Claudia Schepers; Olaf Hoffmann; Christina Röhr; Vincent Prinz; Janett König; Hans Lehrach; Wilfried Nietfeld; George Trendelenburg
Journal:  Biochem Biophys Res Commun       Date:  2007-05-30       Impact factor: 3.575

10.  A crucial role for interleukin (IL)-1 in the induction of IL-17-producing T cells that mediate autoimmune encephalomyelitis.

Authors:  Caroline Sutton; Corinna Brereton; Brian Keogh; Kingston H G Mills; Ed C Lavelle
Journal:  J Exp Med       Date:  2006-07-03       Impact factor: 14.307

View more
  17 in total

1.  MicroRNA-146b-3p regulates the development and progression of cerebral infarction with diabetes through RAF1/P38MAPK/COX-2 signaling pathway.

Authors:  Fan Cai; Fang Wu; Jiumei Cao; Xiaonan Chen
Journal:  Am J Transl Res       Date:  2018-02-15       Impact factor: 4.060

2.  Pharmacokinetic and metabolomic analyses of the neuroprotective effects of salvianolic acid A in a rat ischemic stroke model.

Authors:  Si-Qi Feng; Nan Aa; Jian-Liang Geng; Jing-Qiu Huang; Run-Bin Sun; Chun Ge; Zhi-Jian Yang; Lian-Sheng Wang; Ji-Ye Aa; Guang-Ji Wang
Journal:  Acta Pharmacol Sin       Date:  2017-08-24       Impact factor: 6.150

3.  Acupuncture inhibits TXNIP-associated oxidative stress and inflammation to attenuate cognitive impairment in vascular dementia rats.

Authors:  Si-Qi Du; Xue-Rui Wang; Wen Zhu; Yang Ye; Jing-Wen Yang; Si-Ming Ma; Cai-Shuo Ji; Cun-Zhi Liu
Journal:  CNS Neurosci Ther       Date:  2017-11-06       Impact factor: 5.243

4.  Knockout of silent information regulator 2 (SIRT2) preserves neurological function after experimental stroke in mice.

Authors:  Lea Krey; Fred Lühder; Kathrin Kusch; Bozena Czech-Zechmeister; Birte Könnecke; Tiago Fleming Outeiro; George Trendelenburg
Journal:  J Cereb Blood Flow Metab       Date:  2015-07-29       Impact factor: 6.200

5.  Anti-inflammatory effects of fimasartan via Akt, ERK, and NFκB pathways on astrocytes stimulated by hemolysate.

Authors:  Xiu-Li Yang; Chi Kyung Kim; Tae Jung Kim; Jing Sun; Doeun Rim; Young-Ju Kim; Sang-Bae Ko; Hyunduk Jang; Byung-Woo Yoon
Journal:  Inflamm Res       Date:  2015-11-25       Impact factor: 4.575

6.  Effect of supraglottic airway devices versus endotracheal intubation general anesthesia on outcomes in patients undergoing mechanical thrombectomy: A prospective randomized clinical trial.

Authors:  Jing Zhao; Wenchao Zhu; Yingying Qi; Guangjun Xu; Lei Liu; Jingjing Liu
Journal:  Medicine (Baltimore)       Date:  2022-05-06       Impact factor: 1.817

7.  Ruscogenin Attenuates Cerebral Ischemia-Induced Blood-Brain Barrier Dysfunction by Suppressing TXNIP/NLRP3 Inflammasome Activation and the MAPK Pathway.

Authors:  Guosheng Cao; Nan Jiang; Yang Hu; Yuanyuan Zhang; Guangyun Wang; Mingzhu Yin; Xiaonan Ma; Kecheng Zhou; Jin Qi; Boyang Yu; Junping Kou
Journal:  Int J Mol Sci       Date:  2016-08-29       Impact factor: 5.923

Review 8.  Anti-Inflammatory Effects of Traditional Chinese Medicines against Ischemic Injury in In Vivo Models of Cerebral Ischemia.

Authors:  Chin-Yi Cheng; Yu-Chen Lee
Journal:  Evid Based Complement Alternat Med       Date:  2016-09-15       Impact factor: 2.629

Review 9.  Cellular Stress Response and Immune Signaling in Retinal Ischemia-Reperfusion Injury.

Authors:  Gillipsie Minhas; Jyoti Sharma; Nooruddin Khan
Journal:  Front Immunol       Date:  2016-10-24       Impact factor: 7.561

10.  Co-ultramicronized Palmitoylethanolamide/Luteolin in the Treatment of Cerebral Ischemia: from Rodent to Man.

Authors:  Carlo Caltagirone; Carlo Cisari; Carlo Schievano; Rosanna Di Paola; Marika Cordaro; Giuseppe Bruschetta; Emanuela Esposito; Salvatore Cuzzocrea
Journal:  Transl Stroke Res       Date:  2015-12-26       Impact factor: 6.829

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.